| β Coefficient | Standard error | p-value | |
| Duration of treatment | |||
| First month | ref | ||
| Third month | 11.706 | 0.793 | <0.001 |
| Sixth month | 27.695 | 0.794 | <0.001 |
| Therapeutic regimen | |||
| Only aminoglycosides | ref | ||
| Only bedaquiline | −2.169 | 2.689 | 0.420 |
| Received aminoglycosides followed by bedaquiline | −6.843 | 2.550 | 0.007 |
| Age | |||
| <40 years | ref | ||
| ≥40 years | 6.102 | 1.779 | <0.001 |
| Sex | |||
| Female | ref | ||
| Male | −0.507 | 1.855 | 0.785 |
| Body mass index | |||
| ≥18.5 | ref | ||
| <18.5 | 1.989 | 1.631 | 0.223 |
| Alcohol intake | |||
| No | ref | ||
| Yes | 2.469 | 1.879 | 0.189 |
| Hypertension | |||
| No | ref | ||
| Yes | −1.866 | 4.412 | 0.672 |
| Hemoglobin | |||
| Normal | |||
| Anemia | −1.008 | 2.214 | 0.649 |
| Albumin | |||
| Normal | |||
| Hypoalbuminemia | 5.610 | 1.682 | 0.001 |
| HIV status | |||
| Negative | ref | ||
| Positive | −1.435 | 2.618 | 0.583 |
| CKD | |||
| Stage I | ref | ||
| Stage II | −1.993 | 1.891 | 0.292 |
| Stage III and over | 6.730 | 2.710 | 0.013 |